Tag: CDMO

A contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Services offered by CMOs include, but are not limited to: pre-formulation, formulation development, stability studies, method development, pre-clinical and Phase I clinical trial materials, late-stage clinical trial materials, formal stability, scale-up, registration batches and commercial production. CMOs are contract manufacturers, but they can also be more than that because of the development aspect.

3P Biopharmaceuticals and Affibody in Collaboration Agreement

The arrangement covers process transfer, process development and GMP manufacture of affibody’s candidate. 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufa...

Tergus to Build Plant and Invest in Expanding Commercial Manufacturing

Tergus Pharma (“Tergus”), an end-to-end service provider for topical pharmaceutical research, drug development, testing and manufacturing, has announced a 100,000-square-foot building for its new head...

Sterling Expands its Pilot Plant GMP Facility

Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million inv...

Ampersand Capital Partners Acquires Vibalogics

Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specia...

Vetter’s German Sites Are to Be Supplied with Green Electricity Only

Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has reached another important milestone regarding sustainability. Beginning immediately, all German sites of the c...

Thermo Fisher Acquires Brammer Bio for $1.7bn

Thermo Fisher Scientific Inc., the world leader in serving science, and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, announced they have entered into a definitive a...

CDMO Flamma Built its First cGMP Kilo Lab in Italy

Flamma SpA (“Flamma”), a preeminent Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) f...

Fujifilm to Acquire Biogen Manufacturing Site

FUJIFILM Corporation (“Fujifilm”) today announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød ne...

Recipharm Achieved ISO 45001 in German Facility

Recipharm, the contract development and manufacturing organisation (CDMO), has achieved the new ISO 45001 certification at its Wasserburg facility in Germany. The certification is developed from an ea...

WuXi STA and BioLingus in Exclusive Technology Collaboration

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, announce they have formed an exclusive technology and marketing collaboration for subling...

Fujifilm Partners with Universities to Grow Bioprocessing

Leading contract development and manufacturing organisation (CDMO) Fujifilm Diosynth Biotechnologies has announced a strategic partnership with a number of academic institutions to expand its bioproce...

NextPharma Acquire Finnish Santen’s Facility

NextPharma, a European pharmaceutical contract development and manufacturing organization (CDMO), has agreed to acquire Santen’s Tampere manufacturing facility and associated operations. The acquis...

Olon Acquire Capua BioServices

Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of Capua BioServi...

MHRA Approved Upperton New Facilities

Spray drying specialist has invested in building enhancements and in the expansion of its processing and analytical capabilities The UK Medicines and Healthcare products Regulatory Agency (MHRA) ha...

Fujifilm Invests $90m to Expand its FDB

Fujifilm Corporation announced plans to invest approximately $90 million to expand its bio contract development and manufacturing organization (CDMO) business— Fujifilm Diosynth Biotechnologies (FDB)....

TOBIO Closed $45m Series A Financing to Advance Phase II CDMO

Thousand Oaks Biopharmaceuticals, an integrated global chemistry, manufacturing and controls (CMC) organization including GMP cell culture media and biomanufacturing capabilities, has closed a $45 mil...